Home
NICE Guidance
Conditions and diseases
Digestive tract conditions
Inflammatory bowel disease
Infliximab and adalimumab for the treatment of Crohn's disease
Technology appraisal guidance [TA187]
Published:
19 May 2010
Guidance
Tools and resources
Information for the public
Evidence
History
Shared learning examples
Shared learning examples for Infliximab and adalimumab for the treatment of Crohn's disease
Title
Type
Year published
No results could be found